A quality-adjusted time without symptoms or toxicity analysis identified better outcomes for patients with RCC treated with belzutifan vs everolimus.

Panelists discuss how patient portal use improves communication by allowing patients to report adverse effects with photos ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...

Oncology nurses can assess patients’ risk factors and advocate for preventive strategies that protect kidney function during ...

This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of ...

Panelists discuss treatment considerations for metastatic melanoma with high tumor burden, highlighting the preference for immune checkpoint combinations like nivolumab with relatlimab for durable ...

Based on durable response data, TAR-200 has been given priority review for the treatment of patients with high-risk ...

Panelists discuss how managing amivantamab-related adverse events such as leg edema requires understanding of underlying ...

Panelists discuss how the COCOON study’s advanced dermatologic prophylaxis protocol, including systemic antibiotics and ...